Fossils from three different humans estimated to be about 175,000 years old show a stage of evolutionary development that led to the Neandertals. The jaw fragment reveals signs of reduced chewing force due to food preparation changes, suggesting extensive community support for individuals with difficulty caring for themselves.
A massive star's remnant is discovered in the Milky Way galaxy, moving at an incredible speed of 300,000 miles per hour. The black hole, called XTE J1118+480, was gravitationally ejected from a globular cluster and has consumed its companion star.
Researchers at Dana-Farber Cancer Institute have identified a crucial protein called PGC-1 that regulates glucose production in the liver. This breakthrough could lead to new treatments for diabetes by targeting this protein with future drugs.
Researchers have discovered that chemokine expression plays a crucial role in enhancing antibacterial immunity. This finding is significant for the development of novel therapeutic strategies against bacterial infections.
Researchers reexamine the process of reverse cholesterol transport, a critical mechanism for removing excess cholesterol from peripheral tissues. The study reveals that this process may have both protective and detrimental effects on cardiovascular health.
Researchers have discovered two distinct pathways leading to cell death in the diseased kidney, which could lead to new therapeutic targets for kidney disease. These findings provide a better understanding of kidney pathology and may enable the development of more effective treatments.
UT Southwestern Medical Center has acquired a custom-crafted cryo-electron microscope to propel its cell-research capabilities. The new technology enables the analysis of sub-cell structures at sites in the cell where processes take place, providing valuable insights into cellular biology and disease mechanisms.
Researchers are enrolling patients in a clinical trial to investigate the safety and tolerability of early antiretroviral therapy for recently infected HIV patients. The study aims to determine whether early intervention can reduce disease progression, viral mutations, and immune system damage.